ARK Genomic Revolution ETF
$ARKG · ARK Invest · tracks Actively Managed (ARK Genomic Revolution) · since 2014
Dividend yield
0.00%
Expense ratio
0.75%
Assets
$1.9B
About ARKG
Actively managed ETF focused on companies advancing genomic sequencing, gene editing, molecular diagnostics, and bioinformatics. ARKG targets companies that could benefit from multi-year convergence of biology and technology.
Top holdings
Sector exposure
- Gene Editing32.4%
- Molecular Diagnostics24.8%
- Bioinformatics / AI Drug18.6%
- Cell & Gene Therapy14.2%
- Other10.0%
How StockWorthy analyses ARKG
ETFs hold companies rather than generating cash flow themselves, so ARKG is assessed on cost, income and the valuation of what it owns: the expense ratio, the current yield against its own long-run average, and a holdings-weighted P/E and growth rate built from the underlying positions. Figures are educational and not investment advice.
Sign in to see live pricing, yield history and the full holdings breakdown, or browse all ETFs.